introduction despite development various strategy therapy drug diagnosis treatment cancer remains major cause death worldwide available cancer treatment chemotherapy drug inherent limitation destroy malignant healthy cell resulting destruction metabolically active cell body suppression immune system systemic toxicity increased risk secondary infection cancer patient drug resistance becomes increasingly prevalent growing demand natural agent eradicate primary tumor reduce risk recurrence one natural agent lactoferrin protein belonging transferrin family molecular weight kda consisting approximately amino acid residue although primary function human transport iron blood plasma also posse several biological function including antibacterial antiviral antimicrobial antiparasitic notably antitumor activity highest concentration found human milk followed cow milk lactoferrin composed single polypeptide chain encompasses two lobe joined α-helical residue structural arrangement provides flexibility two lobe consist α-helices β-sheets bind ion synergy carbonate ion protein exists two form apo-lactoferrin iron-free form holo-lactoferrin iron-containing form natural state partially saturated iron however also become fully saturated iron external source lactoferrin extensively studied potential natural agent combating various type cancer including gastric cancer shown highly efficient bio-drug anti-cancer research several in-vitro in-vivo study reported inhibit growth tumor cell diverse mechanism including apoptosis cell cycle arrest cell membrane disruption immunoreaction decreased cell migration cytoskeleton damage stable protein retain effectiveness even passing gastrointestinal tract study shown oral administration result decreased occurrence tongue blf esophageal 0.2 blf lung 0.02 blf carcinogenesis rat discernible impact weight body organ indicative non-toxicnature additionally shown induce cytotoxicity decrease cell proliferation mcf-7 mda-mb-231 human breast cancer cell line lactoferrin stored secondary cytoplasmic granule neutrophil found high concentration site inflammation playing vital role inflammatory response mechanism moreover kidney synthesize contributing immune defence system sequestering free iron urine making available metabolic function cellular level modulates maturation migration differentiation activation proliferation function immune cell using two signaling pathway accumulated neutrophil injury site promotes cell–cell interaction activates phagocytosis polymorphonuclear leukocyte macrophage decrease number pro-inflammatory cytokine increase natural killer cell activity activates lymphocyte furthermore also play valuable role distinguishing normal cell tumor cell tumor cell typically posse highly negative charge compared normal cell rendering susceptible cationic protein like sparing normal cell study shown many cancer cell posse elevated level proteoglycan glycosaminoglycan sialic acid interact protein exert cytotoxic effect cancer cell mechanism explains ability selectively target exert high cytotoxicity selectivity toward cancer cell posing harm healthy cell magnetic nanoparticles properly synthesized made biocompatible play crucial role various biomedical application ranging imaging therapy serve efficient carrier drug delivery small size large surface-to-volume ratio properly functionalized site-specific targeting among various type magnetic nanoparticles iron oxide nanoparticles find common use due magnetic property biocompatibility across variety biomedical application including drug gene delivery biosensors magnetic particle imaging mpi hyperthermia treatment superparamagnetic iron oxide nanoparticles engineered respond specifically efficiently within tumor microenvironment particle magnetized external magnetic field exhibit residual magnetic interaction removal field indicating good dispersion excellent targeting capacity characteristic make highly advantageous magnetic hyperthermia due ability disperse within localized minor region creating difference temperature profile normal tumor cell various particle synthesized harness anti-cancer potential different cancer using hyperthermia treatment mohamadkazem synthesized iron oxide-gold nanocomplexes used external field physically navigate magnetic nanoparticles target melanoma cell effectively killing electron beam therapy kamalabadi synthesized folate-functionalized gold-coated magnetic nanoparticles treating hpv-positive oropharyngeal cancer enhancing uptake cell death application external field hyperthermia found enhance drug release formulation developing potent theranostic agent anti-cancer activity colorectal cancer based hypothesized targeted delivery lactoferrin conjugated iron oxide nanoparticles lf-ionps gastric tissue coupled hyperthermia offer enhanced efficacy treatment gastric cancer material method material ferric chloride fecl ferrous sulfate feso ammonium hydroxide polyethylene glycol peg deionized water analytical grade purchased lobachemie india lactoferrin ammonium hydroxide ethylene dichloride edc n-hydroxysuccinimide ham cell culture medium fetal bovine serum fbs penicillin–streptomycin purchased himedia india synthesis iron oxide nanoparticles followed conjugation lactoferrin synthesize iron oxide nanoparticles fecl ·6h feso ·7h dissolved deionized water heated followed addition peg400 subsequently separate solution containing ammonium hydroxide water rapidly added iron solution stirring followed stirring period min resulting mixture turned black cooled room temperature centrifuged rpm min washed five time water remove undissolved impurity conjugate nanoparticles protein solution prepared mixing mg/ml edc mg/ml naoh synthesized iron oxide nanoparticles added 0.5 sonicated min activate carboxyl group surface next mg/ml added left overnight room temperature resultant solution purified centrifugation 12,000 redispersed phosphate buffer saline three time obtain pure nano-formulation study particle size morphology elemental analysis malvern dls-zeta size analyzer used determine hydrodynamic size surface charge nanoparticles dynamic light scattering zeta study respectively scanning electron microscopy sem jeol jsm-6300 used visualizing small topographic detail surface high-resolution transmission electron microscopy hrtem talos f200s thermo scientific employed identify size shape interface structure lf-ionps prior analysis nanospheres centrifuged rpm min washed eliminate unbound metal salt impurity resulting pellet analyzed using energy dispersive x-ray spectrometer bruker quantax determine percentage present element study lf-ionps interaction using spectroscopy fourier transform infrared spectroscopy ftir technique used determine chemical bond molecule producing infrared absorption spectrum discrete vibrational energy functional group employed identify interaction protein iron oxide nanoparticles ftir study performed using agilent cary series spectrophotometer sample prepared using potassium bromide kbr method scanned surface enhanced raman scattering sers spectrum also utilized monitor structural change protein conjugation iron oxide particle thin film ionps lf-ionps prepared min prior measurement glass slide sample subjected scanning using labram evolution horiba instrument equipped detector microscope record raman spectrum sample silico study identify binding site residue different transition metal ion mib metal ion binding online docking tool used done using fragment transformation method process begin selection protein interest extracted protein data bank pdb query protein compared metal ion database find metal binding residue score assigned binding residue fragment transformation method used align query protein length metal-binding template residue chain aligned manner metal ion binding protein template converted query protein structure certain parameter taken consideration get protein structure firstly metal ion template must contain residue bound transition metal including metal ion secondly length polypeptide chain protein structure must residue order included docking purpose residue query template metal ion binding triplet represented using notation n–ca–c denoting backbone atom xca yca pdb coordinate query protein template written s2.sm s2.sm term triplet third parameter least two metal ion binding residue fourth important parameter residue binding score specified threshold value order considered residue binding particular transition metal ion binding score denoted assigned residue target protein based sequence structural conservation protein using root mean square deviation c-alpha carbon structural local alignment well blosum62 substitution matrix hence binding site metal ion determined using bioinformatics tool way mib tool help determine binding site metal ion particular protein chain example case protein pdb 4eww extracted pdb protein data bank database single chain denoted metal ion docked metal ion-binding template compared target protein xrd analysis x-ray diffraction pattern give deep knowledge chemical composition crystallographic structure physical property material xrd analysis sample first dried subjected radiation 1.54 obtain diffraction pattern material diffraction pattern collected scan range 10°–90° average crystallite size ionps lf-ionps determined employing highest intense peak using scherrer formula d=\frac k\lambda cos\theta 0.9 scherrer constant 1.54 wavelength x-ray broadening highest intense peak crystallite size synthesized nanoparticles includes ionps iron oxide nanoparticles lf-ionps lactoferrin-iron oxide nanospheres hyperthermia study check heating capacity hyperthermia type heat treatment involves raising temperature tumor-loaded tissue type treatment used kill cancer cell little harm normal cell order perform hyperthermia analysis synthesized nanospheres used nanotherics magnetherm magnetic hyperthermia instrument consists optical fiber temperature probe involves analyzing nanospheres magnetic field various frequency including 161.9 khz 242.4 khz 411.1 khz 580.2 khz 935.3 khz determine lowest frequency particle generate safe effective temperature rise treatment purpose vsm study check magnetic property vibrating sample magnetometer vsm lake shore used analyze magnetic property iron oxide nanoparticles sample subjected kilo-oersted magnetic field room temperature obtained hysteresis loop m-h saturation magnetization powdered form sample recorded hysteresis loop explains relationship magnetic flux density magnetizing field strength characteristic ferromagnetic material analyzing hysteresis loop important magnetic property saturation magnetization coercivity remanence obtained drug loading release kinetics studying drug loading efficiency synthesized lf-ionps sample centrifuged 10,000 rpm min concentration protein determined supernatant unbound protein well pellet bound protein using bradford reagent thereafter release kinetics performed placing particle dialysis membrane drug concentration mg/ml temperature entire process release kinetics performed two different 7.4 physiological gastric performing study dialysis membrane suspended beaker distilled water 7.4 physiological volume sample collected beaker different time interval followed addition similar volume distilled water beaker maintain total volume constant similar process followed studying release kinetics gastric water monitor efficient release drug target site thereafter rate release bound pellet observed different time interval taking absorption value absorption value plotted infer trend release drug using bsa standard curve vitro study cytotoxicity study cytotoxicity sample checked cancerous cell line following mtt 4,5-dimethylthiazol-2-yl -2,5-diphenyltetrazolium bromide assay study cell density per well density seeded well plate allowed become confluent 75–80 cell treated using three different concentration 7.5 µg/ml fecl feso ionps lf-ionps following treatment cell incubated incubator post mtt added incubated incubation mtt along medium removed every well plate dmso added min absorbance recorded calculate inhibition percentage following equation used inhibition at/ac test substance absorbance control solvent absorbance similarly mtt assay performed cell treated magnetic hyperthermia check effect hyperthermia treatment cancer cell evaluate anti-cancer potential synthesized nano-formulations cell grown tissue culture plate followed treatment fecl feso ionps lf-ionps let confluent thereafter cell trypsinized resuspended ham medium placed sample holder exposed magnetic hyperthermia treatment min frequency 242.4 khz scratch assay anti-cancer activity confirm anti-cancer activity synthesized formulation scratch assay conducted assay cell seeded 6-well plate allowed grow fbs-free medium ham medium incubator cell reached 80–90 confluency scratch made using pointed object tip cell washed remove debris different sample including iron oxide nanoparticles ionps lf-iron oxide nanospheres lf-ionps applied cell cell incubated image taken mentioned interval period determine percentage change wound diameter formulation distance wound randomly measured distinct position scratch made individual well plate mean independent reading calculated experiment repeated three time record data result discussion structure composition lf-iron oxide nanoparticles formation nanospheres spherical shape average size revealed high-resolution transmission electron microscopic image scale shown fig inset fig scale furthermore field emission scanning electron microscopic image scale depicted fig offer additional evidence iron oxide nanoparticles embedded protein matrix hydrodynamic diameter lf-ionps determined 80.19 see fig figure display energy dispersive x-ray spectroscopy spectrum clearly show presence different element including notably found evenly distributed accounting 8.47 figure characterization lf-ionps hr-tem image scale inset showing size lf-ionps showing hydrodynamic size synthesized lactoferrin-iron oxide nanospheres lf-ionps 80.19 showing iron present lf-ionps 8.47 ftir showing interaction protein iron oxide nanoparticles raman providing structural fingerprint different molecule defined full size image study interaction ionps nanoparticle formation using ftir raman spectrum investigate interaction protein metal ion ftir analysis conducted sample ionps lf-ionps result revealed several peak spectrum provide insight molecular bonding present sample peak observed 533.57 three sample indicating presence fe–o bond another peak fe–n stretch seen 832.74 ionps lf-ionps additionally peak 1069.45 detected three sample representing c–n stretch another peak 1231.81 observed lf-ionps ionps indicating bond amide iii c=o stretching vibration observed 1407.77 three sample furthermore peak 1527.74 1633.32 representing amide amide bond respectively present lf-ionps ionps bond representing c–h stretching vibration present 2852.25 lactoferrin lf-ionps seen ionps 2916.24 represents peak position bond o–h intermolecular interaction observed lactoferrin lf-ionps ionps also amine n–h stretching observed 3282.55 lactoferrin lf-ionps case ionps shown fig table table table give comparative value wavenumbers obtained ftir range 400–4000 raman spectrum 500–1800 respectively lactoferrin ionps lf-ionps indicating change different functional group present thus coin interaction among lactoferrin protein iron oxide nanoparticles leading formation lf-ionps full size table raman analysis performed along ionps lf-ionps identify different molecule based structural fingerprint peak observed 517.61 ionps represents fe–o 578.84 685.71 indicate bond fe–o t2g fe–o a1g respectively also present lf-fe shifted lower wavenumber 666.65 −162 additionally peak 960.45 observed ionps lf-ionps show peak 988.69 fe–o peak 615.81 signifies presence sulfur residue cysteine present lf-fe absent ionps similarly c–s stretch give peak 750.69 lf-ionps ionps peak 774.67 indicates o–c–n bend present three sample another peak 843.41 indicates c–c stretching mode present lf-ionps shifted higher wavenumber 886.73 ionps bond c–o–c present ionps lf-ionps peak position 955.47 absent amide iii present lf-ionps peak position 1227.83 1250.65 respectively peak 1358.96 indicates c–h bend observed l-ionps ionps peak 1449.36 signifies presence amide bond lf-ionps ferric hydroxide peak seen 1556.23 present three sample amide bond 1665.69 present lf-ionps absent ionps finally c=o stretch observed lf-ionps 1774.87 peak observed ionps wavenumber result presented fig table overall result ftir raman spectroscopy indicate difference chemical bonding interaction metal ion providing insight interaction protein metal ion key finding ftir raman spectroscopy analysis indicate distinct molecular bonding interaction metal ion evidenced presence fe–o c–n amide iii amide amide bond lf-ionps ionps result provide valuable insight specific nature protein-metal ion interaction silico study determine interaction protein utilized mib metal ion binding software online docking server predict binding site interaction metal ion amino acid residue protein depends structure sequence extracted human protein pdb pdb 1b0l docked metal ion using mib binding residue protein assigned binding score residue score higher threshold considered binding site determined distance metal ion binding site chain calculated using maestro observed three binding site specific amino acid residue 435y 597h 395d 528y distance measured 8.14 6.10 4.45 7.84 respectively 60d 92y 192y 253h distance 4.73 8.18 7.89 6.14 respectively 604d distance 4.65 4.65 respectively shown fig fig binding potential graph different amino acid residue illustrated fig figure metal ion binding residue showing binding amino acid chain lactoferrin protein binding amino acid 435y 597h 395d 528y distance measured 8.14 6.10 4.45 7.84 respectively binding amino acid 393s 395d 597h 644n distance 6.4 5.28 3.77 4.89 respectively full size image seven binding site involving specific amino acid site varying distance metal ion 393s 395d 597h 644n distance 6.4 5.28 3.77 4.89 respectively 393s 413e 597h 644n distance found 6.59 4.99 3.06 5.23 respectively 60d 253h distance 4.39 7.05 3.84 7.73 respectively 60d 253h showed distance 4.45 7.92 3.90 6.50 respectively metal ion amino acid 431p 654h distance 4.81 3.45 respectively 60d 253h showed distance 4.85 7.39 4.41 5.94 respectively 47q 51e distance 8.35 6.77 respectively shown fig fig moreover binding potential shown fig schematic representation conjugation lactoferrin ionps employing edc/nhs coupling reaction synthesize lf-ionps illustrated fig figure figure show schematic representation synthesis procedure depicts schematic representation conjugation lactoferrin protein iron oxide nanoparticles achieved edc/ coupling reaction full size image xrd analysis x-ray diffraction conducted ass crystallinity material fig show xrd diffraction pattern iron oxide nanoparticles ionps lactoferrin protein lactoferrin-iron oxide nanoparticles lf-ionps diffraction peak observed xrd pattern ionps appearing 30° 35° 43° 52° 57° 62° correspond crystal plane peak match well peak shown 00-003-0863 icdd number diffraction pattern iron oxide lactoferrin-iron oxide nanoshperes lf-ionps observed position iron oxide particle suggesting addition lactoferrin iron oxide nanoparticles doe significantly alter crystalline structure hand xrd pattern lactoferrin protein alone peak broad hump observed range 23°–25° indicates presence amorphous material lack distinct sharp peak associated crystalline structure crystallite size ionps lf-ionps determined scherrer formula reported table table saturation magnetization remanence coercivity crystallite size bare ionps lactoferrin coated iron oxide nanoparticles lf-ionps full size table hyperthermia study understand magnetic hyperthermia heating effect nanoparticles temperature time profile recorded varying frequency keeping field strength time constant frequency sample subjected hyperthermia treatment min period time hyperthermia temperature achieved beyond time overheating take place conducting experiment initial temperature machine found increase frequency 161.9 242.4 khz 411.1 khz 580.2 935.3 khz linear increase temperature generated 33.26 38.34 50.56 55.54 66.26 respectively illustrated fig show temperature max frequency khz plot temperature rise indicates nanoparticles potential use magnetic hyperthermia treatment cancerous tissue sar value also calculated mentioned frequency given table figure determination hyperthermia responsiveness lf-ionps figure illustrates heating capacity lf-iron oxide nanospheres different frequency constant magnetic field show temperature rise i.e. 33.26 38.34 50.56 55.54 66.26 different frequency 161.9 khz 242.4 khz 411.1 khz 580.2 khz 935.3 khz respectively m-h loop ionps lf-ionps measured room temperature plot display release kinetic study conducted determine percentage drug release lf-ionps graph represents drug release per mg/ml mtt assay determined cytotoxic activity cell absence presence hyperthermia data show treatment cell control including salt solution fecl feso ionps lf-ionps concentration µg/ml 7.5 µg/ml µg/ml sample absence presence hyperthermia treatment data plotted mean three independent experiment full size image magnetic property magnetic property bare lactoferrin coated iron oxide nanoparticles determined magnetization measurement m–h measurement performed room temperature lakeshore model field range koe m–h loop ionps lf-ionps presented fig hysteresis loop saturation magnetization coercivity remanence determined reported table table seen remanence coercivity ionps lf-ionps nearly zero indicating synthesized nanoparticles superparamagnetic indicates room temperature thermal energy overcome magnetic anisotropy energy keep randomly oriented absence external magnetic field lf-ionps also posse high saturation magnetization making suitable candidate magnetic hyperthermia application drug loading release kinetics encapsulation efficiency protein ionps found 0.014 drug release monitored 7.4 drug release observed physiological 7.4 however perform study gastric drug observed burst release first followed sustained release next end 92.18 0.003 drug released highlighting efficiency lf-ionps drug delivery system fig shown fig in-vitro cell line study presence absence hyperthermia evaluate cytotoxicity lf-ionps cancer cell line performed mtt assay physiological condition cytotoxicity calculated fecl feso salt solution protein ionps lf-ionps three concentration µg/ml 7.5 µg/ml µg/ml three independent set prepared concentration along control assay performed without hyperthermia treatment determine efficacy treatment mtt assay without hyperthermia treatment cell treated fecl salt solution showed cell viability 98.67 4.5 µg/ml 96.65 5.8 7.5 µg/ml 95.38 µg/ml similarly feso -treated cell showed cell viability 97.61 1.62 µg/ml 96.44 6.15 7.5 µg/ml 94.32 3.74 µg/ml cell treated showed cell viability 98.35 1.2 µg/ml 93.58 5.8 7.5 µg/ml 77.87 4.5 µg/ml cell treated ionps cell viability 98.06 11.80 µg/ml 93.48 7.03 7.5 µg/ml 85.03 3.95 µg/ml finally cell treated lf-ionps showed cell viabilityof 85.56 4.25 µg/ml 85.21 7.06 7.5 µg/ml 81.69 3.76 µg/ml concentration incubation period cell subjected hyperthermia treatment frequency 242.4 khz min mtt assay performed determine effect synthesized formulation cell viability treated cell showed significant increase cytotoxicity compared control group fecl salt solution-treated cell cell viability 95.38 3.9 µg/ml 92.62 10.4 7.5 µg/ml 91.88 µg/ml cell treated feso salt solution cell viability 94.11 0.77 µg/ml 92.73 9.54 7.5 µg/ml 91.14 0.49 µg/ml lf-treated cell cell viability level 61.53 3.9 60.26 10.4 40.95 concentration µg/ml 7.5 µg/ml µg/ml respectively hand cell treated ionps showed cell viability level 52.36 0.77 µg/ml 41.53 9.54 7.5 µg/ml 35.70 0.49 µg/ml lastly lf-ionps resulted cell viability level 49.33 36.18 9.7 32.25 5.2 µg/ml 7.5 µg/ml µg/ml respectively result provide substantial evidence cytotoxic nature synthesized nanospheres cancerous cell explored anti-cancerous activity data shown fig table show value calculated variation cell viability treatment 7.5 µg/ml ionps lf-ionps without hyperthermia statistical significance data considered 0.05 comparative data presented table scratch assay anti-cancer activity order ass impact lf-ionps migration ability cell scratch assay employed cell exposed fixed concentration µg/ml lf-ionps iron oxide nanoparticles ionps determine percentage change scratch diameter diameter measured three distinct position scratch mean diameter individual reading scratch calculated control cell exhibited gap percentage 26.19 0.35 46.42 0.30 54.76 0.35 66.66 0.35 respectively contrast cell treated ionps showed gap percentage 12.85 0.26 34.52 0.17 46.19 0.39 50.47 0.07 56.19 0.44 time interval furthermore lf-treated cell displayed even greater inhibition percentage 11.90 0.35 30.95 0.35 38.09 0.35 47.61 0.17 51.42 0.16 respectively lf-ionps treatment showed inhibition percentage 4.76 0.35 21.42 0.60 33.33 0.35 42.85 0.60 47.61 0.35 respectively result indicated lf-ionps treatment significantly inhibited cell migration compared control cell almost filled gap within finding support nanoparticles anti-cancerous property demonstrated fig determine statistical significance data value calculated scratch assay treatment comparative data presented table figure figure show anti-cancer effect nanoparticles using cell line via scratch assay control cell ionps treated cell fixed concentration µg/ml treated cell concentration µg/ml cell treated lf-ionps µg/ml concentration plot showing comparison change scratch diameter post-treatment ionps lf-ionps including control full size image conclusion investigate potential nanoparticles anti-cancer agent used lactoferrin protein capping agent iron oxide nanoparticles component demonstrated anti-cancer activity lactoferrin interacts high level proteoglycan glycosaminoglycan sialic acid found cancer cell activates signaling pathway exert cytotoxic effect gastric cancer cell iron oxide nanoparticles synthesized using co-precipitation method linked lactoferrin protein edc-nhs activates carboxyl group surface iron oxide particle facilitating conjugation protein synthesized particle exhibited desirable hr-tem size demonstrated notable heating capacity exposed external magnetic field successfully conjugating lactoferrin iron oxide nanoparticles achieved targeted delivery gastric cancer cell lactoferrin known interact proteoglycan glycosaminoglycan sialic acid present surface cancer cell furthermore lactoferrin iron oxide nanoparticles showed potent synergistic anti-cancer activity cancer cell line low concentration particle easily internalized cell line synthesized lf-ionps lactoferrin conjugated iron oxide nanospheres showed remarkable increase anti-cancer property compared individual component significantly enhanced efficacy combined great degree selectivity attributed conjugation ionps remarkable superparamagnetic behavior substantial magnetization capacity excellent heating capacity nanospheres hold great promise use numerous area biomedical research application strongly believe synthesized particle great potential target different type cancer cell line effectively hope finding paper inspire research future use anti-cancer nanoparticles